CSIMarket
 
Progyny Inc   (NASDAQ: PGNY)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $27.3800 $-0.38 -1.369%
Day's High: $27.920000076293945 Week Perf: 1.11 %
Day's Low: $ 27.15 30 Day Perf: 8.09 %
Volume (M): 864,463 52 Wk High: $ 33.06
Volume (M$): $ 0 52 Wk Avg: $23.64
Open: $27.63 52 Wk Low: $16.10



 Market Capitalization (Millions $) 2,249
 Shares Outstanding (Millions) 82
 Employees 856
 Revenues (TTM) (Millions $) 1,311
 Net Income (TTM) (Millions $) 79
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 23

Business Description


Progyny Inc is a leading provider of employer-sponsored fertility benefits and care.
The company provides comprehensive fertility solutions to self-insured employers, large enterprises, and employees, addressing the broad range of needs individuals face when seeking fertility care.
It uses advanced technology and data analytics to provide personalized care plans and cost-effective, evidence-based treatments.
Progyny's mission is to provide support, education, and assistance to individuals struggling to achieve their dream of starting a family.
Its emphasis on personalized care plans and proactive guidance sets it apart from traditional fertility benefits providers.
The company has developed strong partnerships with top-tier fertility clinics, enabling it to offer the latest and most advanced treatments to its patients.
With a robust portfolio of services, Progyny offers a full suite of fertility benefits, including fertility assessments, FDA-approved medications, egg freezing, in-vitro fertilization (IVF), genetic testing, and surrogacy services.
Its proprietary platform, called "PURE," provides members with easy access to patient-centric care and support services, including telemedicine consultations with fertility specialists, virtual support groups, and personalized health coaching.
Progyny's innovative approach to fertility care has earned it several accolades, including being named one of the "50 Smartest Companies" by MIT Technology Review and one of the "Most Innovative Companies" in healthcare by Fast Company.
The company has also been recognized for its emphasis on employee well-being, earning multiple awards and recognition for being a great place to work.
Overall, Progyny Inc is a rapidly-growing company that's reshaping the fertility benefits industry by providing a comprehensive suite of personalized care services to individuals seeking to start families.
Its focus on innovative technology, a broad network of high-quality clinics, and a patient-centric approach provides members with the support and resources they need to achieve their fertility goals.


   Company Address: 1359 Broadway New York 10018 NY
   Company Phone Number: 888-3124   Stock Exchange / Ticker: NASDAQ PGNY


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
COO   -13.97%    
INM   -3.82%    
RANI   -10%    
• View Complete Report
   



Product Service News

Breaking Barriers How New Research Challenges Mens Fertility Stigma

Published Thu, Nov 20 2025 3:07 PM UTC

In recent findings published by Progyny, a leading fertility and family-building benefits management company, men s attitudes toward fertility have taken center stage. The study reveals compelling insights that challenge preconceived notions surrounding men s involvement in fertility discussions and the barriers they face when seeking support. Key Findings1. Shared Respons...

Partnership

Progyny Partners with Amazon A Step Forward in Women’s Health and Family Building Amidst Growing Competitiveness

Published Wed, Jun 11 2025 8:18 AM UTC

In a groundbreaking partnership, Progyny Inc. has become the first women’s health and family building solution to join Amazon s Health Benefits Connector Program. This collaboration promises to empower Amazon customers eligible for Progyny services by facilitating their access to vital fertility, family building, and menopause benefits. The initiative is not just about off...

Merger and Acquisition

Progyny Inc. Expands Services with Concierge Model for Parental Leave Planning Following Acquisition of Berlin-Based Apryl

Published Tue, Jan 28 2025 1:44 PM UTC

Breaking News: Progyny Inc. Introduces Concierge-Level Service for Expecting Parents Amid Strategic AcquisitionIn a significant development for expecting parents, Progyny Inc. (NASDAQ: PGNY) has unveiled a revolutionary concierge-level service model designed specifically to provide expert guidance, navigation, and support for parental leave planning. The new initiative aims ...

Merger and Acquisition

Progyny, Inc. Amplifies Worldwide Services by Acquiring Apryl, a Berlin-based Fertility Benefits Platform

Published Mon, Jun 24 2024 11:00 AM UTC


New York, June 24, 2024 - Progyny, Inc. (Nasdaq: PGNY), a leading fertility, family building, and women s health benefits solution, has made a significant stride towards expanding its global offerings with the recent acquisition of Apryl, a fertility benefits platform based in Berlin. The acquisition marks an important milestone for Progyny, as it further strengthens th...

Partnership

Progyny and Fertility Matters Canada Collaborate to Champion Expanded Access to Family Building Care in Canadian Fertility Awareness Week

Published Wed, Apr 17 2024 1:24 PM UTC

In a remarkable show of support, Progyny and Fertility Matters Canada, two leading organizations in the field of fertility care, have come together to recognize and advocate for Canadian Fertility Awareness Week. This joint effort aims to raise awareness about the challenges faced by millions of individuals and couples in need of family building care across the country. As t...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 29.76
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.72
Price to Sales (Expected) -
Price to Book 4.96
PEG (TTM) 0.51

Financial Strength Current
Quick Ratio 0.99
Working Capital Ratio 2.29
Leverage Ratio (MRQ) 0.58
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0.92 $
Revenues (TTM) 15.96 $
Cash Flow (TTM) -
Cash 2.88 $
Book Value 5.52 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 1,531,890
Net Income per Employee (TTM) 91,861
Receivable Turnover Ratio (TTM) 5.28
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 1.78

Profitability Ratios Current
Gross Margin (MRQ) 25.48 %
Operating Margin (MRQ) 11.41 %
Net Margin (MRQ) 8 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 34.38 %

Management Effectiveness Current
Return On Assets (TTM) 10.66 %
Return On Investment (TTM) 15.25 %
Return On Equity (TTM) 15.98 %
Dividend Yield -
Pay out Ratio (TTM) -



Progyny Inc's Segments
Fertility benefit services revenue    125.43 % of total Revenue
Pharmacy benefit services revenue    68.29 % of total Revenue
Reportable    193.72 % of total Revenue

  Progyny Inc Outlook

On February 27 2025 the Progyny Inc provided following guidance

nnProgyny, Inc. Projects Continued Growth for 2025 Following Strong Q4 2024 Performancenn

Progyny, Inc. has recently announced its financial results for the fourth quarter of 2024, showcasing a robust quarterly revenue of $298.4 million, which signifies a commendable growth rate of 10.6% compared to the previous quarter. Additionally, the company reported an impressive operating cash flow of $52.2 million, highlighting its strong financial performance during this period.

In light of these encouraging results, Progyny has also provided financial guidance for the year 2025, underscoring an anticipated continuation of growth. This guidance marks the company's commitment to achieving revenue gr...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.